Sarah Beck
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disinfection | 13 | 2025 | 124 | 3.140 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 13 | 2024 | 86 | 2.700 |
Why?
| | Water Purification | 9 | 2024 | 152 | 2.660 |
Why?
| | Ultraviolet Rays | 10 | 2024 | 396 | 2.610 |
Why?
| | Disinfectants | 2 | 2025 | 39 | 1.790 |
Why?
| | Levivirus | 4 | 2025 | 18 | 1.760 |
Why?
| | Simian Immunodeficiency Virus | 12 | 2024 | 88 | 1.750 |
Why?
| | Virus Inactivation | 2 | 2025 | 13 | 1.160 |
Why?
| | Virus Latency | 5 | 2019 | 80 | 1.120 |
Why?
| | Macaca nemestrina | 7 | 2017 | 29 | 1.030 |
Why?
| | Disease Models, Animal | 19 | 2024 | 4295 | 1.000 |
Why?
| | Laundering | 1 | 2025 | 1 | 0.950 |
Why?
| | Textiles | 1 | 2025 | 22 | 0.920 |
Why?
| | Sodium Hypochlorite | 1 | 2024 | 4 | 0.920 |
Why?
| | Monkeypox virus | 1 | 2024 | 17 | 0.910 |
Why?
| | Macaca mulatta | 9 | 2024 | 166 | 0.900 |
Why?
| | Water Microbiology | 4 | 2022 | 85 | 0.880 |
Why?
| | Escherichia coli | 6 | 2024 | 815 | 0.840 |
Why?
| | CD4-Positive T-Lymphocytes | 8 | 2020 | 1091 | 0.820 |
Why?
| | RNA, Viral | 3 | 2016 | 656 | 0.760 |
Why?
| | Virus Replication | 6 | 2019 | 483 | 0.730 |
Why?
| | AIDS Dementia Complex | 3 | 2017 | 51 | 0.720 |
Why?
| | Central Nervous System | 3 | 2018 | 258 | 0.700 |
Why?
| | Vascularized Composite Allotransplantation | 4 | 2023 | 31 | 0.690 |
Why?
| | HIV Infections | 7 | 2020 | 2836 | 0.640 |
Why?
| | Germinal Center | 1 | 2019 | 58 | 0.620 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2019 | 900 | 0.580 |
Why?
| | HIV-1 | 3 | 2019 | 864 | 0.580 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2016 | 203 | 0.540 |
Why?
| | Macrophages | 7 | 2019 | 1547 | 0.530 |
Why?
| | Viral Load | 9 | 2021 | 466 | 0.510 |
Why?
| | SAIDS Vaccines | 1 | 2016 | 4 | 0.500 |
Why?
| | Vaccines, Virus-Like Particle | 1 | 2016 | 3 | 0.500 |
Why?
| | Gene Products, gag | 1 | 2016 | 36 | 0.490 |
Why?
| | Microbial Viability | 1 | 2015 | 91 | 0.470 |
Why?
| | Anti-Retroviral Agents | 5 | 2024 | 233 | 0.470 |
Why?
| | Blood Platelets | 4 | 2024 | 408 | 0.440 |
Why?
| | Coronavirus Infections | 4 | 2021 | 364 | 0.440 |
Why?
| | DNA Damage | 2 | 2014 | 420 | 0.440 |
Why?
| | B-Lymphocytes | 1 | 2019 | 847 | 0.430 |
Why?
| | Animals | 44 | 2024 | 36940 | 0.430 |
Why?
| | Skin Transplantation | 3 | 2024 | 85 | 0.400 |
Why?
| | Adenoviridae | 1 | 2013 | 193 | 0.400 |
Why?
| | Disease Susceptibility | 1 | 2015 | 347 | 0.400 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 383 | 0.380 |
Why?
| | Thrombosis | 3 | 2023 | 371 | 0.380 |
Why?
| | Osteoma, Osteoid | 1 | 2011 | 4 | 0.370 |
Why?
| | Antiviral Agents | 1 | 2017 | 744 | 0.360 |
Why?
| | Graft Rejection | 5 | 2023 | 624 | 0.350 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 77 | 0.350 |
Why?
| | Hemostasis | 2 | 2024 | 82 | 0.340 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2023 | 40 | 0.330 |
Why?
| | Tibia | 1 | 2011 | 178 | 0.320 |
Why?
| | Hydrogen Peroxide | 2 | 2024 | 328 | 0.320 |
Why?
| | Bone Neoplasms | 1 | 2011 | 247 | 0.300 |
Why?
| | Skin | 3 | 2024 | 752 | 0.300 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 2 | 2019 | 8 | 0.290 |
Why?
| | Water | 2 | 2022 | 460 | 0.290 |
Why?
| | Diarrhea | 2 | 2020 | 184 | 0.270 |
Why?
| | Antibodies, Viral | 2 | 2021 | 625 | 0.260 |
Why?
| | Calcium Signaling | 2 | 2020 | 249 | 0.250 |
Why?
| | Monkey Diseases | 2 | 2016 | 20 | 0.240 |
Why?
| | Detergents | 1 | 2025 | 44 | 0.230 |
Why?
| | Heart Transplantation | 2 | 2022 | 754 | 0.230 |
Why?
| | Pressure | 3 | 2014 | 225 | 0.230 |
Why?
| | Stainless Steel | 1 | 2024 | 20 | 0.230 |
Why?
| | Wood | 1 | 2024 | 16 | 0.230 |
Why?
| | Glass | 1 | 2024 | 45 | 0.230 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2024 | 52 | 0.230 |
Why?
| | Neuroticism | 1 | 2024 | 19 | 0.220 |
Why?
| | Common Cold | 1 | 2024 | 13 | 0.220 |
Why?
| | CCR5 Receptor Antagonists | 2 | 2014 | 6 | 0.220 |
Why?
| | Cyclohexanes | 2 | 2014 | 21 | 0.220 |
Why?
| | Humans | 29 | 2025 | 137585 | 0.210 |
Why?
| | Surface Properties | 1 | 2024 | 413 | 0.210 |
Why?
| | Nerve Regeneration | 1 | 2023 | 59 | 0.200 |
Why?
| | Growth Hormone | 1 | 2023 | 101 | 0.200 |
Why?
| | Neuroglia | 1 | 2024 | 173 | 0.200 |
Why?
| | Personality | 1 | 2024 | 132 | 0.200 |
Why?
| | Thrombocytopenia | 1 | 2024 | 200 | 0.200 |
Why?
| | Triazoles | 2 | 2014 | 147 | 0.200 |
Why?
| | Regeneration | 1 | 2024 | 197 | 0.190 |
Why?
| | Brain | 4 | 2019 | 2668 | 0.190 |
Why?
| | Cation Transport Proteins | 1 | 2023 | 134 | 0.190 |
Why?
| | Organ Preservation Solutions | 1 | 2022 | 45 | 0.190 |
Why?
| | Cricetinae | 4 | 2024 | 289 | 0.190 |
Why?
| | Spinal Cord | 1 | 2024 | 370 | 0.180 |
Why?
| | Myeloid Cells | 2 | 2019 | 148 | 0.180 |
Why?
| | Wound Healing | 1 | 2024 | 331 | 0.180 |
Why?
| | Hand Hygiene | 1 | 2020 | 9 | 0.170 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2019 | 13 | 0.170 |
Why?
| | Mice | 14 | 2024 | 17787 | 0.170 |
Why?
| | Myocutaneous Flap | 1 | 2020 | 10 | 0.170 |
Why?
| | Superficial Back Muscles | 1 | 2020 | 14 | 0.170 |
Why?
| | Swine | 5 | 2021 | 775 | 0.170 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2015 | 346 | 0.160 |
Why?
| | Disease Progression | 2 | 2020 | 2757 | 0.160 |
Why?
| | Ethanol | 1 | 2024 | 608 | 0.160 |
Why?
| | Pancreas | 2 | 2019 | 329 | 0.160 |
Why?
| | Photoacoustic Techniques | 1 | 2019 | 6 | 0.160 |
Why?
| | Hyperthermia, Induced | 1 | 2020 | 116 | 0.160 |
Why?
| | Immunoconjugates | 1 | 2021 | 114 | 0.160 |
Why?
| | Clinical Laboratory Techniques | 1 | 2020 | 97 | 0.160 |
Why?
| | Severity of Illness Index | 4 | 2021 | 2828 | 0.160 |
Why?
| | Homeostasis | 1 | 2023 | 621 | 0.160 |
Why?
| | Recovery of Function | 1 | 2023 | 653 | 0.150 |
Why?
| | Bacteroides fragilis | 1 | 2018 | 13 | 0.150 |
Why?
| | Lung | 6 | 2021 | 4060 | 0.150 |
Why?
| | Hindlimb | 1 | 2019 | 128 | 0.150 |
Why?
| | Soil | 1 | 2020 | 230 | 0.150 |
Why?
| | Mammaplasty | 1 | 2020 | 105 | 0.150 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2018 | 36 | 0.150 |
Why?
| | Fiducial Markers | 1 | 2018 | 9 | 0.140 |
Why?
| | Equipment Contamination | 1 | 2018 | 67 | 0.140 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2018 | 35 | 0.140 |
Why?
| | Agriculture | 1 | 2019 | 103 | 0.140 |
Why?
| | Cross Reactions | 1 | 2018 | 133 | 0.140 |
Why?
| | Cone-Beam Computed Tomography | 1 | 2018 | 39 | 0.140 |
Why?
| | Diastole | 2 | 2015 | 149 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 430 | 0.140 |
Why?
| | Genome-Wide Association Study | 1 | 2024 | 1431 | 0.140 |
Why?
| | Th17 Cells | 1 | 2018 | 108 | 0.140 |
Why?
| | Potassium Compounds | 1 | 2017 | 10 | 0.140 |
Why?
| | Atrazine | 1 | 2017 | 8 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.130 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 322 | 0.130 |
Why?
| | Sulfates | 1 | 2017 | 50 | 0.130 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2018 | 351 | 0.130 |
Why?
| | Receptors, Virus | 1 | 2016 | 83 | 0.130 |
Why?
| | Meningitis | 1 | 2017 | 79 | 0.130 |
Why?
| | Sunlight | 1 | 2017 | 73 | 0.130 |
Why?
| | Syk Kinase | 1 | 2016 | 21 | 0.130 |
Why?
| | Male | 18 | 2024 | 67762 | 0.130 |
Why?
| | Gene Expression | 2 | 2024 | 1502 | 0.120 |
Why?
| | Safety | 1 | 2018 | 338 | 0.120 |
Why?
| | Encephalitis | 1 | 2017 | 136 | 0.120 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2017 | 271 | 0.120 |
Why?
| | Arterial Occlusive Diseases | 1 | 2016 | 83 | 0.120 |
Why?
| | Colitis | 1 | 2018 | 266 | 0.120 |
Why?
| | Anti-Infective Agents | 1 | 2018 | 255 | 0.120 |
Why?
| | Immune Evasion | 1 | 2016 | 58 | 0.120 |
Why?
| | Lymphocytes | 1 | 2017 | 397 | 0.120 |
Why?
| | Immunotherapy | 1 | 2020 | 641 | 0.120 |
Why?
| | Mice, Transgenic | 4 | 2024 | 2167 | 0.120 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2016 | 141 | 0.120 |
Why?
| | Primary Cell Culture | 1 | 2016 | 171 | 0.120 |
Why?
| | Neurons | 1 | 2024 | 1590 | 0.120 |
Why?
| | Viral Proteins | 1 | 2017 | 342 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Vitamin B 12 | 1 | 2016 | 128 | 0.120 |
Why?
| | Cryptosporidium parvum | 1 | 2014 | 13 | 0.120 |
Why?
| | Pyridones | 1 | 2016 | 168 | 0.110 |
Why?
| | Endometriosis | 1 | 2015 | 51 | 0.110 |
Why?
| | Nanoparticles | 1 | 2020 | 481 | 0.110 |
Why?
| | Receptor, trkB | 1 | 2015 | 33 | 0.110 |
Why?
| | Mice, Inbred C57BL | 6 | 2024 | 5757 | 0.110 |
Why?
| | Iron | 1 | 2017 | 313 | 0.110 |
Why?
| | Antitubercular Agents | 1 | 2016 | 206 | 0.110 |
Why?
| | HIV Fusion Inhibitors | 1 | 2014 | 3 | 0.110 |
Why?
| | Polymers | 1 | 2018 | 490 | 0.110 |
Why?
| | Ventricular Dysfunction | 1 | 2014 | 15 | 0.110 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2015 | 131 | 0.110 |
Why?
| | Ventricular Function | 1 | 2014 | 61 | 0.110 |
Why?
| | Water Pollutants, Chemical | 1 | 2017 | 215 | 0.110 |
Why?
| | Neuroprotective Agents | 1 | 2015 | 131 | 0.110 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2013 | 141 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 400 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 976 | 0.100 |
Why?
| | Platelet Activation | 2 | 2024 | 93 | 0.100 |
Why?
| | Fibrinolytic Agents | 1 | 2016 | 270 | 0.100 |
Why?
| | Microglia | 1 | 2016 | 251 | 0.100 |
Why?
| | Myocardial Contraction | 1 | 2015 | 341 | 0.100 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 623 | 0.100 |
Why?
| | Extracellular Vesicles | 1 | 2015 | 146 | 0.100 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2014 | 128 | 0.100 |
Why?
| | Nasopharyngeal Diseases | 1 | 2012 | 5 | 0.100 |
Why?
| | Sheep Diseases | 1 | 2012 | 8 | 0.100 |
Why?
| | Alleles | 1 | 2016 | 891 | 0.100 |
Why?
| | Bacteriophages | 1 | 2014 | 98 | 0.100 |
Why?
| | Nasal Polyps | 1 | 2012 | 59 | 0.090 |
Why?
| | Lizards | 1 | 2012 | 35 | 0.090 |
Why?
| | Mesocricetus | 2 | 2021 | 39 | 0.090 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2031 | 0.090 |
Why?
| | Radiography | 2 | 2011 | 822 | 0.090 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 363 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 806 | 0.090 |
Why?
| | Hydrogels | 1 | 2018 | 678 | 0.090 |
Why?
| | Mice, Nude | 2 | 2024 | 698 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2013 | 1062 | 0.090 |
Why?
| | Liver | 1 | 2019 | 1943 | 0.090 |
Why?
| | Helicobacter Infections | 1 | 2010 | 32 | 0.080 |
Why?
| | Rodent Diseases | 1 | 2010 | 28 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 1 | 2016 | 916 | 0.080 |
Why?
| | Carcinoma | 1 | 2012 | 240 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 938 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 409 | 0.080 |
Why?
| | Immunoglobulin M | 2 | 2021 | 289 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1996 | 0.080 |
Why?
| | Heart Ventricles | 1 | 2014 | 788 | 0.080 |
Why?
| | Breeding | 1 | 2008 | 64 | 0.070 |
Why?
| | Immunocompromised Host | 1 | 2010 | 202 | 0.070 |
Why?
| | Spinal Diseases | 1 | 2008 | 48 | 0.070 |
Why?
| | Intervertebral Disc | 1 | 2008 | 39 | 0.070 |
Why?
| | Mice, Knockout | 4 | 2018 | 3015 | 0.070 |
Why?
| | Dog Diseases | 1 | 2008 | 64 | 0.070 |
Why?
| | Thyroid Neoplasms | 1 | 2012 | 343 | 0.070 |
Why?
| | Graft Survival | 2 | 2021 | 535 | 0.070 |
Why?
| | Spleen | 2 | 2019 | 514 | 0.070 |
Why?
| | Bacteria | 1 | 2014 | 858 | 0.070 |
Why?
| | Vaccination | 1 | 2016 | 1381 | 0.070 |
Why?
| | Female | 12 | 2024 | 73304 | 0.070 |
Why?
| | Biomarkers | 2 | 2015 | 4149 | 0.070 |
Why?
| | Chemokine CCL2 | 2 | 2019 | 115 | 0.060 |
Why?
| | Monocytes | 2 | 2019 | 563 | 0.060 |
Why?
| | Calcinosis | 1 | 2008 | 235 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2021 | 893 | 0.060 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3412 | 0.060 |
Why?
| | Thrombopoiesis | 1 | 2024 | 8 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2019 | 2531 | 0.060 |
Why?
| | Megakaryocytes | 1 | 2024 | 34 | 0.060 |
Why?
| | Platelet Factor 4 | 1 | 2024 | 35 | 0.060 |
Why?
| | Mutation | 1 | 2016 | 3958 | 0.060 |
Why?
| | Toll-Like Receptors | 1 | 2024 | 185 | 0.050 |
Why?
| | TRPC6 Cation Channel | 1 | 2023 | 3 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2023 | 114 | 0.050 |
Why?
| | Forelimb | 1 | 2023 | 29 | 0.050 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2023 | 36 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2018 | 956 | 0.050 |
Why?
| | Calcium | 2 | 2023 | 1199 | 0.050 |
Why?
| | Cations | 1 | 2023 | 84 | 0.050 |
Why?
| | Dogs | 2 | 2018 | 413 | 0.050 |
Why?
| | Multifactorial Inheritance | 1 | 2024 | 174 | 0.050 |
Why?
| | Magnesium | 1 | 2023 | 156 | 0.050 |
Why?
| | Platelet Aggregation | 1 | 2023 | 103 | 0.050 |
Why?
| | RNA, Transfer | 1 | 2024 | 138 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1242 | 0.050 |
Why?
| | Gluconates | 1 | 2022 | 5 | 0.050 |
Why?
| | Disaccharides | 1 | 2022 | 19 | 0.050 |
Why?
| | Axons | 1 | 2024 | 198 | 0.050 |
Why?
| | Pandemics | 2 | 2021 | 1639 | 0.050 |
Why?
| | Dextrans | 1 | 2022 | 84 | 0.050 |
Why?
| | Acute Disease | 1 | 2024 | 1007 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2024 | 2607 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2021 | 90 | 0.050 |
Why?
| | Organ Preservation | 1 | 2022 | 102 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2019 | 4193 | 0.040 |
Why?
| | Perfusion | 1 | 2022 | 213 | 0.040 |
Why?
| | Abatacept | 1 | 2021 | 53 | 0.040 |
Why?
| | Democratic Republic of the Congo | 1 | 2020 | 30 | 0.040 |
Why?
| | Interferon-beta | 1 | 2021 | 92 | 0.040 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2020 | 28 | 0.040 |
Why?
| | Magnetic Fields | 1 | 2020 | 24 | 0.040 |
Why?
| | Stromal Interaction Molecule 1 | 1 | 2020 | 10 | 0.040 |
Why?
| | Logistic Models | 2 | 2020 | 2074 | 0.040 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 99 | 0.040 |
Why?
| | Serologic Tests | 1 | 2020 | 54 | 0.040 |
Why?
| | Glutathione | 1 | 2022 | 356 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 146 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 109 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 143 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2020 | 332 | 0.040 |
Why?
| | Upper Extremity | 1 | 2021 | 99 | 0.040 |
Why?
| | Antibody Formation | 1 | 2021 | 298 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2021 | 211 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1738 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1809 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2019 | 39 | 0.040 |
Why?
| | Chemokine CXCL10 | 1 | 2019 | 39 | 0.040 |
Why?
| | Blood Cells | 1 | 2019 | 40 | 0.040 |
Why?
| | Macaca | 1 | 2019 | 56 | 0.040 |
Why?
| | Hepatic Veins | 1 | 2019 | 33 | 0.040 |
Why?
| | Swine, Miniature | 1 | 2019 | 82 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 206 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2020 | 128 | 0.040 |
Why?
| | Laparotomy | 1 | 2019 | 109 | 0.040 |
Why?
| | Trinitrobenzenesulfonic Acid | 1 | 2018 | 10 | 0.040 |
Why?
| | Ischemia | 1 | 2022 | 409 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 425 | 0.040 |
Why?
| | Tacrolimus | 1 | 2020 | 199 | 0.040 |
Why?
| | Lasers | 1 | 2019 | 130 | 0.040 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2018 | 20 | 0.040 |
Why?
| | Genome, Viral | 1 | 2019 | 144 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 246 | 0.040 |
Why?
| | Robotics | 1 | 2019 | 94 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2019 | 247 | 0.040 |
Why?
| | Inflammation | 2 | 2020 | 2837 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2021 | 1272 | 0.040 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2024 | 630 | 0.040 |
Why?
| | Interleukin-17 | 1 | 2018 | 119 | 0.040 |
Why?
| | Duodenum | 1 | 2018 | 78 | 0.030 |
Why?
| | Estradiol | 1 | 2021 | 521 | 0.030 |
Why?
| | Feces | 1 | 2020 | 484 | 0.030 |
Why?
| | Pyrimidines | 1 | 2021 | 470 | 0.030 |
Why?
| | Pyrazinamide | 1 | 2016 | 12 | 0.030 |
Why?
| | Virus Internalization | 1 | 2016 | 49 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2018 | 217 | 0.030 |
Why?
| | Rural Population | 1 | 2020 | 563 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2016 | 135 | 0.030 |
Why?
| | Isoniazid | 1 | 2016 | 63 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2016 | 269 | 0.030 |
Why?
| | Rifampin | 1 | 2016 | 84 | 0.030 |
Why?
| | Transgenes | 1 | 2016 | 180 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2017 | 560 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1077 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1129 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 580 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2071 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2016 | 186 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2020 | 890 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 752 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2018 | 886 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1622 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5647 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 585 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 816 | 0.030 |
Why?
| | Receptors, CCR5 | 1 | 2014 | 56 | 0.030 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 286 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2014 | 100 | 0.030 |
Why?
| | Nerve Fibers | 1 | 2014 | 96 | 0.030 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 61 | 0.030 |
Why?
| | Administration, Oral | 1 | 2016 | 816 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2016 | 364 | 0.030 |
Why?
| | Epidermis | 1 | 2014 | 157 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1066 | 0.030 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 350 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2014 | 108 | 0.030 |
Why?
| | Cornea | 1 | 2014 | 138 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1710 | 0.020 |
Why?
| | Cytokines | 1 | 2021 | 2085 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3284 | 0.020 |
Why?
| | Animals, Zoo | 1 | 2012 | 12 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1250 | 0.020 |
Why?
| | Plasma | 1 | 2013 | 212 | 0.020 |
Why?
| | Ligands | 1 | 2014 | 664 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2015 | 1316 | 0.020 |
Why?
| | Thyroxine | 1 | 2012 | 62 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2057 | 0.020 |
Why?
| | Thyroid Gland | 1 | 2012 | 94 | 0.020 |
Why?
| | Signal Transduction | 2 | 2016 | 5079 | 0.020 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 385 | 0.020 |
Why?
| | Hypothyroidism | 1 | 2012 | 72 | 0.020 |
Why?
| | Hyperplasia | 1 | 2012 | 175 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 852 | 0.020 |
Why?
| | Child | 1 | 2011 | 21935 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2012 | 303 | 0.020 |
Why?
| | Motor Activity | 1 | 2016 | 718 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1916 | 0.020 |
Why?
| | Antigens, CD | 1 | 2013 | 521 | 0.020 |
Why?
| | Helicobacter | 1 | 2010 | 4 | 0.020 |
Why?
| | Omeprazole | 1 | 2010 | 7 | 0.020 |
Why?
| | Clarithromycin | 1 | 2010 | 28 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 971 | 0.020 |
Why?
| | Metronidazole | 1 | 2010 | 20 | 0.020 |
Why?
| | Antigens, CD1 | 1 | 2010 | 58 | 0.020 |
Why?
| | Complement Factor D | 1 | 2010 | 30 | 0.020 |
Why?
| | Amoxicillin | 1 | 2010 | 35 | 0.020 |
Why?
| | Sheep | 1 | 2012 | 856 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1113 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1793 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2014 | 526 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1774 | 0.020 |
Why?
| | Drug Combinations | 1 | 2010 | 343 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 7604 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3556 | 0.020 |
Why?
| | Phenotype | 1 | 2016 | 3196 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5778 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 11074 | 0.020 |
Why?
| | Risk Factors | 1 | 2019 | 10388 | 0.010 |
Why?
| | Time Factors | 1 | 2016 | 6828 | 0.010 |
Why?
| | Aged | 1 | 2024 | 23961 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 10811 | 0.010 |
Why?
| | Incidence | 1 | 2008 | 2804 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2008 | 2844 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3295 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 2426 | 0.010 |
Why?
|
|
Beck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|